In this study, we showed that exposure of human prostate cancer cells to sub-lethal doses of cisplatin or LA-12 resulted in profound potentiation of TRAIL-induced cell death that involved activation of mitochondrial apoptotic pathway, and investigated the novel molecular mechanisms behind the cooperative action of the drugs. Here, TNFSF10 is linked to prostate carcinoma.